E6M: Residues 1 -158 of HPV16 E6 were cloned into a modified pET-DUET (Invitrogen) vector. The resulting protein, 6xHis-SUMO-E6, was expressed overnight at 18 °C in Escherichia. coli BL21 (520) cells with 750 µM isopropyl ß-D-1-thiogalactopyranoside (IPTG) and 100 µM zinc acetate. Cells were lysed by sonication in 20 mM Hepes, pH 7.5, 500 mM sodium chloride (NaCl), 10 mM ß-mercaptoethanol (BME), 10 µM zinc acetate, 5 mM imidazole and 1 mM phenylmethylsulfonyl fluoride (PMSF). Protein was immobilized on Ni-NTA resin (Qiagen), washed with buffer containing 30 mM imidazole and eluted with a gradient of 30 -500 mM imidazole.
Spectrum and HitFinder compounds were tested at final concentrations of 10 µM and the OPS library was screened at final concentrations of 6 -10 µM. The Spectrum library was screened with a single compound per well in duplicate, while the to deconvolute the orthogonally compressed data for both HitFinder and OPS. The data was grouped into four categories: actives (compounds that displayed > 50% inhibition of E6-E6AP binding and mapped to a unique well in both the horizontal and vertical direction), ambiguous (compounds that mapped to two or more wells in either dimension), orphan (compounds that displayed inhibition in one direction but not the other) and inactive compounds. The software was a very convenient tool to 'bin' the data into these active categories as described by others (44).
Thermal Stability Assay
Individual 20 µL reactions were set up with 4 µM E6M, a 1:1000 dilution of SYPRO orange (Invitrogen), 10 µM compound (final DMSO concentration of 1%) and buffer with a final concentration of 20 mM Hepes, pH 7.5, 500 mM NaCl, and 10 mM BME. Thermal melt curves were obtained by heating the protein from 20˚C to 80˚C and monitoring fluorescence at 580 nm using a 7900HT Fast Real Time PCR System (Applied Biosystems). Negative control reactions of each compound alone were also performed to show that their fluorescent properties did not change over the temperature range of the experiment and ensure that fluorescence was directly representative of E6M melting only (data not shown).
In Vitro Pull-Down Assays
For pulldowns of E6M and MBP-E6AP, 50 μL of resin was pre-equilibrated with 20 mM Hepes, pH 7.5, 500 mM NaCl, 10 mM BME. 30 μg of matching tagged protein was added with an equimolar amount of the partner protein, excess buffer, and incubated at 4°C for one hour on the nutator. Resin was washed with buffer and then 6 proteins were resolved on SDS-PAGE gel to determine extent of binding between the proteins. Negative controls were performed with tag alone plus the partner protein.
For pulldowns of MBP-E6AP and E6M-GST in the presence of inhibitors, 25 µg MBP-E6AP was incubated for 30 minutes at 4˚C with 25 µL amylose resin (New England Biolabs) that was prewashed in binding buffer (20 mM Hepes, pH 7.5, 500 mM NaCl, 10 mM BME, and 0.05% TWEEN20). An equal molar amount of E6M-GST was incubated with the indicated concentrations of compound for 1 hour at 20˚C. 150 µL of the E6M-GST/compound mixture was then transferred to tubes containing MBP-E6AP/beads to a final volume of 450 µL and allowed to incubate at 4°C for 60 minutes with gentle rotation. Resin was washed with buffer then subjected to SDS-PAGE followed by Western analyses (anti-MBP (1:15000, New England Biolabs), anti-GST (1:5000, Calbiochem)).
In vitro p53 Degradation Assay
In vitro translation: Full length, wild-type human p53 was cloned into the pRSETa vector (Invitrogen). Full length, wild type human papillomavirus type 16 or 18 E6 was cloned into the pET28a vector (EMD Biosciences). Using the TNT T7 coupled rabbit reticulocyte lysate systems (Promega), each protein was translated in separate reactions.
Degradation: Individual 10 µL degradation reactions were prepared with 2 µL p53 translation reaction, 5 µL E6 translation reaction, 0.1 µL compound, and 2.9 µL buffer in a final concentration of 20 mM Tris, pH 7.5, 100 mM NaCl, and 2 mM DTT.
Positive control reactions included 0.1 µL DMSO; negative control reactions included 0.1 µL DMSO and 5 µL of a blank translation reaction instead of the E6 translation reaction.
All reactions were incubated at 30˚C for 2.5 hours. Reactions were then mixed with SDS loading dye and heated at 90˚C for five minutes.
Western Blotting: 3 µL of each reaction was run out on a 12% SDS-PAGE gel, transferred to PVDF membrane and then probed with either anti-p53 (1:5000, Bp53-12, Santa Cruz Biotechnology) or anti-beta actin (1:1000, Abcam) followed by anti-mouse conjugated to HRP (1:5000, Bio-RAD). Bands were visualized by chemiluminesence (Pierce) and exposure to film (Kodak).
Cell Maintenance
SiHa, HCT116 and HeLa cells were grown in 1x minimal eagle's media (MEM, Cellgro) supplemented with 10% fetal bovine serum (Hyclone), 10 µg mL -1 penicillinstreptomycin (Cellgro), 2 mM ι-glutamine (Cellgro), 1 mM sodium pyruvate (Cellgro), and 100 µM non-essential amino acids (Gibco) Compound 9, which is reportedly an E6/E6AP binding inhibitor, (from Baleja et al (34)) was tested over a range of concentrations and showed a dose response of blocking E6 binding to E6AP in the ELISA assay that we used. Therefore, we are confident that the compounds we identified in our high-throughput screen disrupt the E6/E6AP c The thermal stability result is as described in the text.
